Likewise, several studies have evaluated the correlation between overall survival time and HDAC2 expression in breast carcinomas of women and reported no significant difference in the survival time of patients (Muller et al., 2013; Derr et al., 2014). The gene discussed is HDAC2; the disease is breast carcinoma.